Gene symbol   |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
Acaa1a | |
NM_130864 |
acetyl-Coenzyme A acyltransferase 1A (Acaa1a), mRNA [NM_130864] |
KLA | 1.53 |
1.60 |
1.88 |
2.07 |
2.41 |
2.64 |
1.82 |
| ATP | 1.07 |
.99 |
.98 |
1.10 |
.94 |
.83 |
1.58 |
| KLA/ATP | 1.64 |
1.64 |
1.73 |
1.75 |
1.61 |
1.39 |
1.85 |
|
Acaa1b | |
NM_146230 |
acetyl-Coenzyme A acyltransferase 1B (Acaa1b), mRNA [NM_146230] |
KLA | 1.52 |
1.66 |
1.93 |
2.04 |
2.32 |
2.51 |
1.83 |
| ATP | 1.04 |
.95 |
1.06 |
1.12 |
1.03 |
.93 |
1.59 |
| KLA/ATP | 1.76 |
1.72 |
1.76 |
1.95 |
1.76 |
1.51 |
1.86 |
|
Acox1 | |
NM_015729 |
acyl-Coenzyme A oxidase 1, palmitoyl (Acox1), mRNA [NM_015729] |
KLA | .79 |
.81 |
.78 |
.68 |
.66 |
.69 |
.82 |
| ATP | .97 |
1.09 |
.93 |
.90 |
.81 |
.78 |
1.22 |
| KLA/ATP | .81 |
.82 |
.69 |
.68 |
.59 |
.70 |
.88 |
|
Acox3 | |
NM_030721 |
acyl-Coenzyme A oxidase 3, pristanoyl (Acox3), mRNA [NM_030721] |
KLA | .56 |
.56 |
.63 |
.55 |
.50 |
.48 |
.68 |
| ATP | 1.10 |
1.00 |
.85 |
.76 |
.87 |
.44 |
.73 |
| KLA/ATP | .61 |
.66 |
.57 |
.49 |
.57 |
.48 |
.47 |
|
Fads2 | |
NM_019699 |
fatty acid desaturase 2 (Fads2), mRNA [NM_019699] |
KLA | .84 |
.82 |
.87 |
.71 |
.55 |
.37 |
.31 |
| ATP | 1.04 |
1.10 |
1.03 |
1.27 |
.98 |
.58 |
.49 |
| KLA/ATP | .84 |
.83 |
.86 |
.97 |
.72 |
.44 |
.23 |
|
Hrasls3 | |
AK052657 |
0 day neonate kidney cDNA, RIKEN full-length enriched library, clone:D630015C01 product:H-REV 107 PROTEIN homolog [Rattus norvegicus], full insert sequence. [AK052657] |
KLA | 4.07 |
4.01 |
2.57 |
2.26 |
1.94 |
1.66 |
1.10 |
| ATP | .93 |
.92 |
1.00 |
.96 |
.95 |
.99 |
1.08 |
| KLA/ATP | 3.36 |
2.63 |
1.76 |
1.26 |
1.41 |
1.22 |
1.27 |
|
Hrasls3 | |
NM_139269 |
HRAS like suppressor 3 (Hrasls3), mRNA [NM_139269] |
KLA | 11.37 |
10.85 |
12.50 |
16.13 |
13.98 |
17.12 |
6.64 |
| ATP | .86 |
.78 |
.96 |
.89 |
.84 |
.99 |
1.03 |
| KLA/ATP | 8.90 |
10.50 |
15.81 |
13.10 |
11.95 |
11.16 |
10.19 |
|
Mm.16006 7 | |
124487226 |
Unknown |
KLA | .90 |
.88 |
.87 |
.85 |
.80 |
.85 |
.64 |
| ATP | .95 |
.95 |
1.00 |
.94 |
1.00 |
.91 |
.67 |
| KLA/ATP | .89 |
.86 |
.93 |
.82 |
.85 |
.84 |
.63 |
|
Mm.29150 3 | |
34328333 |
Unknown |
KLA | .61 |
.60 |
.60 |
.53 |
.51 |
.56 |
.69 |
| ATP | 1.05 |
.96 |
.93 |
.75 |
.81 |
.44 |
.78 |
| KLA/ATP | .66 |
.58 |
.67 |
.52 |
.58 |
.47 |
.55 |
|
Mm.33050 7 | |
67906182 |
Unknown |
KLA | .94 |
.98 |
.99 |
1.03 |
1.05 |
1.07 |
.98 |
| ATP | .95 |
1.02 |
.97 |
.98 |
.99 |
1.05 |
1.02 |
| KLA/ATP | 1.02 |
1.05 |
1.01 |
1.03 |
.99 |
.98 |
.97 |
|
Mm.71913
| |
118130231 |
Unknown |
KLA | .93 |
1.00 |
1.06 |
.97 |
.95 |
.98 |
1.04 |
| ATP | 1.00 |
.98 |
1.08 |
1.02 |
.92 |
.90 |
.99 |
| KLA/ATP | .99 |
1.01 |
1.00 |
.99 |
.99 |
.99 |
1.01 |
|
Pla2g10 | |
NM_011987 |
phospholipase A2, group X (Pla2g10), mRNA [NM_011987] |
KLA | .99 |
1.11 |
1.02 |
.99 |
1.00 |
1.01 |
1.02 |
| ATP | 1.02 |
.97 |
1.01 |
1.03 |
1.00 |
1.02 |
1.04 |
| KLA/ATP | 1.04 |
.96 |
.95 |
1.04 |
1.06 |
1.05 |
1.01 |
|
Pla2g12a
| |
NM_023196 |
phospholipase A2, group XIIA (Pla2g12a), transcript variant 1, mRNA [NM_023196] |
KLA | 1.03 |
1.06 |
.97 |
1.00 |
.78 |
.75 |
.92 |
| ATP | .91 |
.99 |
1.29 |
1.30 |
1.20 |
1.48 |
1.71 |
| KLA/ATP | .92 |
.99 |
1.19 |
1.16 |
1.06 |
1.12 |
1.36 |
|
Pla2g12a
| |
NM_183423 |
phospholipase A2, group XIIA (Pla2g12a), transcript variant 2, mRNA [NM_183423] |
KLA | .90 |
1.00 |
.87 |
.95 |
.76 |
.68 |
.88 |
| ATP | .96 |
.94 |
1.26 |
1.24 |
1.19 |
1.47 |
1.88 |
| KLA/ATP | .89 |
.90 |
1.08 |
1.07 |
1.06 |
1.02 |
1.59 |
|
Pla2g12b
| |
NM_023530 |
phospholipase A2, group XIIB (Pla2g12b), mRNA [NM_023530] |
KLA | .98 |
.95 |
1.05 |
.99 |
1.03 |
.99 |
.94 |
| ATP | 1.02 |
1.04 |
1.07 |
1.05 |
.92 |
1.04 |
1.00 |
| KLA/ATP | .98 |
.92 |
1.10 |
1.11 |
1.09 |
1.03 |
1.04 |
|
Pla2g1b | |
NM_011107 |
phospholipase A2, group IB, pancreas (Pla2g1b), mRNA [NM_011107] |
KLA | 1.00 |
1.01 |
1.01 |
1.11 |
1.00 |
1.28 |
1.00 |
| ATP | .98 |
1.03 |
1.09 |
1.03 |
1.01 |
1.02 |
1.04 |
| KLA/ATP | .93 |
.94 |
1.01 |
1.00 |
.94 |
1.09 |
1.07 |
|
Pla2g2a | |
NM_001082531 |
phospholipase A2, group IIA (platelets, synovial fluid) (Pla2g2a), mRNA [NM_001082531] |
KLA | 1.08 |
.99 |
1.00 |
1.06 |
.98 |
1.01 |
.94 |
| ATP | 1.07 |
.98 |
1.04 |
1.06 |
.90 |
.98 |
.98 |
| KLA/ATP | .98 |
1.03 |
1.00 |
1.04 |
.94 |
.97 |
.96 |
|
Pla2g2c | |
NM_008868 |
phospholipase A2, group IIC (Pla2g2c), mRNA [NM_008868] |
KLA | .98 |
.99 |
1.05 |
.98 |
1.01 |
1.00 |
1.04 |
| ATP | 1.08 |
1.06 |
1.09 |
.93 |
.92 |
.92 |
1.00 |
| KLA/ATP | 1.03 |
1.04 |
1.02 |
1.04 |
.98 |
1.01 |
1.02 |
|
Pla2g2d | |
NM_011109 |
phospholipase A2, group IID (Pla2g2d), mRNA [NM_011109] |
KLA | 1.02 |
1.02 |
.99 |
.99 |
1.00 |
1.01 |
1.00 |
| ATP | .95 |
1.11 |
1.10 |
1.11 |
.98 |
.99 |
1.12 |
| KLA/ATP | 1.02 |
1.00 |
1.19 |
1.11 |
1.00 |
.96 |
1.01 |
|
Pla2g2e | |
NM_012044 |
phospholipase A2, group IIE (Pla2g2e), mRNA [NM_012044] |
KLA | .78 |
.75 |
.74 |
.72 |
.62 |
.69 |
1.40 |
| ATP | 1.06 |
1.00 |
.92 |
1.04 |
.83 |
.76 |
3.74 |
| KLA/ATP | .78 |
.80 |
.69 |
.74 |
.70 |
.74 |
2.24 |
|
Pla2g2f | |
NM_012045 |
phospholipase A2, group IIF (Pla2g2f), mRNA [NM_012045] |
KLA | 1.02 |
.99 |
1.03 |
1.01 |
1.00 |
.95 |
.99 |
| ATP | 1.01 |
1.06 |
1.11 |
.97 |
1.09 |
1.11 |
.99 |
| KLA/ATP | 1.10 |
1.05 |
1.04 |
.95 |
1.04 |
1.01 |
.96 |
|
Pla2g3 | |
NM_172791 |
phospholipase A2, group III (Pla2g3), mRNA [NM_172791] |
KLA | 1.04 |
1.05 |
1.02 |
1.01 |
1.04 |
1.11 |
1.00 |
| ATP | .96 |
.97 |
1.10 |
.91 |
.99 |
.97 |
1.08 |
| KLA/ATP | 1.03 |
1.11 |
1.10 |
.98 |
.95 |
.98 |
1.07 |
|
Pla2g4a | |
NM_008869 |
phospholipase A2, group IVA (cytosolic, calcium-dependent) (Pla2g4a), mRNA [NM_008869] |
KLA | 3.93 |
4.49 |
4.86 |
6.40 |
6.44 |
3.10 |
1.68 |
| ATP | 1.13 |
1.36 |
1.27 |
1.30 |
1.02 |
5.37 |
1.47 |
| KLA/ATP | 3.64 |
4.45 |
4.76 |
7.11 |
2.96 |
4.08 |
2.60 |
|
Pla2g4b | |
NM_145378 |
phospholipase A2, group IVB (cytosolic) (Pla2g4b), mRNA [NM_145378] |
KLA | 1.09 |
1.18 |
.95 |
1.01 |
.97 |
.97 |
.77 |
| ATP | 1.05 |
1.14 |
1.28 |
.94 |
.88 |
1.18 |
.70 |
| KLA/ATP | 1.23 |
1.43 |
1.21 |
1.02 |
1.15 |
1.16 |
.78 |
|
Pla2g4c | |
AK145339 |
1 cell embryo 1 cell cDNA, RIKEN full-length enriched library, clone:I0C0013F18 product:weakly similar to Cytosolic phospholipase A2 gamma [Homo sapiens], full insert sequence [AK145339] |
KLA | 1.09 |
1.21 |
1.33 |
1.17 |
1.26 |
1.30 |
1.05 |
| ATP | .97 |
1.06 |
1.00 |
.98 |
.98 |
.98 |
1.05 |
| KLA/ATP | 1.19 |
1.16 |
1.18 |
1.13 |
1.04 |
1.02 |
1.06 |
|
Pla2g4c | |
NM_001004762 |
phospholipase A2, group IVC (cytosolic, calcium-independent) (Pla2g4c), mRNA [NM_001004762] |
KLA | .93 |
1.00 |
.94 |
.93 |
.94 |
.94 |
.96 |
| ATP | .98 |
.96 |
1.13 |
.97 |
.99 |
.89 |
.96 |
| KLA/ATP | 1.01 |
1.01 |
1.07 |
1.01 |
.94 |
1.01 |
.92 |
|
Pla2g4e | |
AK049063 |
0 day neonate cerebellum cDNA, RIKEN full-length enriched library, clone:C230096D22 product:hypothetical Lysophospholipase catalytic domain containing protein, full insert sequence. [AK049063] |
KLA | 1.03 |
1.09 |
1.01 |
1.01 |
1.06 |
.94 |
1.05 |
| ATP | 1.03 |
1.00 |
1.06 |
1.01 |
.96 |
1.05 |
1.05 |
| KLA/ATP | .98 |
1.00 |
1.01 |
.98 |
1.03 |
.95 |
1.01 |
|
Pla2g4e | |
NM_177845 |
phospholipase A2, group IVE (Pla2g4e), mRNA [NM_177845] |
KLA | .97 |
.95 |
1.01 |
.97 |
1.02 |
1.03 |
1.05 |
| ATP | .98 |
.99 |
1.00 |
1.10 |
.98 |
1.00 |
1.02 |
| KLA/ATP | 1.05 |
.93 |
.96 |
1.03 |
1.08 |
1.05 |
.99 |
|
Pla2g4f | |
NM_001024145 |
phospholipase A2, group IVF (Pla2g4f), mRNA [NM_001024145] |
KLA | 1.08 |
.99 |
1.04 |
1.02 |
1.04 |
.98 |
1.01 |
| ATP | .99 |
1.04 |
.99 |
1.03 |
1.12 |
1.01 |
1.25 |
| KLA/ATP | .97 |
1.04 |
1.10 |
1.06 |
1.04 |
1.03 |
1.03 |
|
Pla2g5 | |
NM_011110 |
phospholipase A2, group V (Pla2g5), transcript variant 2, mRNA [NM_011110] |
KLA | .65 |
.62 |
.56 |
.53 |
.62 |
1.60 |
3.01 |
| ATP | .90 |
.82 |
.88 |
1.69 |
1.82 |
1.26 |
6.32 |
| KLA/ATP | .63 |
.59 |
.65 |
.63 |
.91 |
1.56 |
5.59 |
|
Pla2g6 | |
NM_016915 |
phospholipase A2, group VI (Pla2g6), mRNA [NM_016915] |
KLA | .60 |
.59 |
.56 |
.60 |
.94 |
1.31 |
1.59 |
| ATP | 1.10 |
1.14 |
.95 |
1.05 |
1.06 |
1.13 |
1.14 |
| KLA/ATP | .63 |
.56 |
.54 |
.56 |
.71 |
.97 |
1.55 |
|
Plb1 | |
AK015993 |
adult male testis cDNA, RIKEN full-length enriched library, clone:4930539A06 product:weakly similar to PHOSPHOLIPASE B [Rattus norvegicus], full insert sequence. [AK015993] |
KLA | .99 |
.99 |
1.05 |
1.02 |
1.03 |
1.07 |
1.02 |
| ATP | 1.04 |
1.03 |
1.07 |
1.06 |
1.09 |
1.01 |
1.02 |
| KLA/ATP | 1.07 |
1.00 |
.96 |
1.09 |
1.05 |
1.08 |
1.01 |
|
Plb1 | |
AK087596 |
2 days pregnant adult female oviduct cDNA, RIKEN full-length enriched library, clone:E230021C09 product:hypothetical protein, full insert sequence. [AK087596] |
KLA | .93 |
.99 |
.99 |
1.07 |
.98 |
1.00 |
.98 |
| ATP | 1.08 |
1.00 |
.97 |
1.07 |
1.04 |
1.09 |
.96 |
| KLA/ATP | 1.06 |
.96 |
1.00 |
.98 |
1.04 |
1.06 |
.98 |
|
Plb1 | |
NM_001081407 |
phospholipase B1 (Plb1), mRNA [NM_001081407] |
KLA | 1.05 |
1.09 |
1.05 |
1.04 |
1.05 |
1.03 |
.85 |
| ATP | .96 |
1.03 |
1.02 |
.95 |
1.06 |
1.01 |
.92 |
| KLA/ATP | 1.00 |
1.00 |
1.09 |
1.00 |
.97 |
.99 |
.86 |
|